The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Seattle Genetics Inc

Nasdaq: SGEN
Last

(U.S.) $65.34

Today's change-1.70 -2.54%
Updated April 21 4:00 PM EDT. Delayed by at least 15 minutes.
 

Seattle Genetics Inc

Nasdaq: SGEN
Last

(U.S.) $65.34

Today's change-1.70 -2.54%
Updated April 21 4:00 PM EDT. Delayed by at least 15 minutes.

Seattle Genetics Inc down (U.S.)$1.70

Seattle Genetics Inc closed sharply lower Friday, dropping (U.S.)$1.70 or 2.54% to (U.S.)$65.34. Shares have lost 1.01% over the last five days, but have gained 23.82% over the last year to date. This security has outperformed the S&P 500 by 53.83% during the last year.

Key company metrics

  • Open(U.S.) $66.82
  • Previous close(U.S.) $67.04
  • High(U.S.) $67.12
  • Low(U.S.) $65.16
  • Bid / Ask(U.S.) $56.02 / (U.S.) $0.00
  • YTD % change+23.82%
  • Volume453,681
  • Average volume (10-day)574,884
  • Average volume (1-month)657,795
  • Average volume (3-month)935,641
  • 52-week range(U.S.) $32.40 to (U.S.) $75.36
  • Beta2.30
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.99
Updated April 21 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue10510695111
Total other revenue--------
Total revenue10510695111
Gross profit949585102
Total cost of revenue12111010
Total operating expense161139129132
Selling / general / administrative41353330
Research & development108938693
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-56-32-33-21
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-55-32-33-20
Income after tax-55-32-33-20
Income tax, total--------
Net income-55-32-33-20
Total adjustments to net income--------
Net income before extra. items-55-32-33-20
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-55-32-33-20
Inc. avail. to common incl. extra. items-55-32-33-20
Diluted net income-55-32-33-20
Dilution adjustment--------
Diluted weighted average shares142141140140
Diluted EPS excluding extraordinary itemsvalue per share-0.39-0.23-0.23-0.15
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.39-0.23-0.23-0.15